[FATE] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
28-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 40.17%
YoY- 29.60%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 1,676 44,356 17,067 15,896 2,802 1,661 1,027 8.50%
PBT -44,122 -56,363 -68,621 -53,112 -28,302 -16,027 -12,497 23.38%
Tax 18,832 -8,056 -2,206 -861 691 817 -131 -
NP -44,122 -48,307 -68,621 -53,112 -28,302 -16,027 -12,497 23.38%
Tax Rate - - - - - - - -
Total Cost 45,798 92,663 85,688 69,008 31,104 17,688 13,524 22.53%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -2,632.58 -108.91 -402.07 -334.12 -1,010.06 -964.90 -1,216.85 13.71%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.45 -0.50 -0.72 -0.61 -0.37 -0.25 -0.29 7.59%
EPS Diluted -0.45 -0.50 -0.72 -0.61 -0.37 -0.25 -0.29 7.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.